Safety and efficacy of fingolimod in iranian patients with relapsing-remitting multiple sclerosis

Authors
Category Primary study
JournalBasic and Clinical Neuroscience
Year 2021
This article has no abstract
Epistemonikos ID: a77db7a0f77eb4c9eda895a581994acb89590d97
First added on: Mar 31, 2022